Follow
Cancer
Cancer: is a disease in which abnormal cells divide uncontrollably and destroy body tissue. Cancerous tumors are malignant, which means they can spread into, or invade, nearby tissues.
SEP 17, 2024 | 9:00 AM
Discover the latest innovations in cervical cancer prevention and molecular diagnostics. This event will showcase cutting-edge advancements in integrated molecular automation and innovative...
SEP 12, 2024 | 8:00 AM
Neoantigens are among the newest promising targets for cancer treatment. Unlike tumor-associated antigens, neoantigens are produced only by tumor cells. These unique molecular markers are hi...
SEP 12, 2024 | 10:00 AM
Personalized treatment plans for blood cancers rely on the specialized skills of clinical laboratorians using a variety of analytic methods ranging from microscopic examination to molecular...
AUG 27, 2024 | 9:00 AM
C.E. CREDITS
Join Dr. Steben and Dr. Riedel in their discussion of the HPV landscape and the shift to primary screening. Dr. Steben will set the scene with a discussion of: HPV prevention and prevalence...
AUG 14, 2024 | 3:00 PM
The Molecular Twin is a proof-of-principle platform that combines data from several clinical and molecular analytes from both tumor and host and applies AI and machine learning approaches to...
July 30, 2024 9am PDT, 11am CDT, 12pm EDT
Liquid Biopsy: Understand the significance of liquid biopsy in cancer research and the role of magnetic beads in sample preparation: After listening to the podcast, learners will be able to...
JUL 24, 2024 | 11:00 PM
C.E. CREDITS
Spatial transcriptomics offers a revolutionary approach to understanding the tumor microenvironment (TME) in solid tumors by preserving the spatial context of gene expression, which is cruci...
JUL 16, 2024 | 10:00 PM
Cell health assessment is the foundation in cancer drug discovery. Potential cancer drug candidates need to show anti-cancer activity such as inhibition of proliferation and induction of apo...
JUL 10, 2024 | 10:00 AM
Dr. Jim Richter and Dr. Clara Latorre will walk through the ever changing landscape of cervical screening and management. Cervical screening supports both pap cytology and HPV testing, depen...
JUN 27, 2024 | 6:00 AM
C.E. CREDITS
High-resolution spatial transcriptomics stands at the forefront of technological advancements, offering transformative capabilities in the domain of tumor biology research. In this presentat...
JUN 25, 2024 | 9:00 PM
Over 95% of potential anti-cancer drugs failed in clinical trials despite vast investment to bring the drug to market. The last decade of cancer research has also seen numerous advances aime...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
JUN 19, 2024 | 1:30 PM
Early detection and management of early-stage cancers are keys for improved quality of life, survival, and to reduce the financial burden of cancer treatments which are much greater at later...
JUN 18, 2024 | 9:00 AM
Homologous recombination repair deficiency (HRD) is associated with response to poly-ADP-ribose polymerase inhibition (PARPi) therapy in advanced ovarian cancer. In combination with CGP, the...
JUN 11, 2024 | 8:00 AM
Cancer genome alterations that cause cancer cells to grow also confer vulnerabilities, which normal cells lack. The challenge is that, for the majority of cancers, we do not understand the r...
JUN 04, 2024 | 9:15 AM
HPV-negative head and neck squamous cell carcinoma (HNSCC) poses challenges for treatment, particularly with limited response to immunotherapy. We investigated tumor-infiltrating lymphocytes...
JUN 04, 2024 | 8:45 AM
Cancer immunotherapy approaches such as adoptive transfer of chimeric antigen receptor (CAR) T cells or tumor-infiltrating lymphocytes have yielded promising results in hematological maligna...
MAY 22, 2024 | 8:00 AM
Precision medicine aims to match the right therapy to the right patient at the right time, improving efficacy and reducing side effects. In this webinar, Dr. Hsu discusses his work to develo...
MAY 16, 2024 | 3:00 PM
C.E. CREDITS
Prostate cancer is the most common cancer in men and is second most common cause of cancer deaths. Importantly, the annual rates of prostate cancer incidence continue to rise. This session w...
MAY 15, 2024 | 12:00 PM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
MAY 15, 2024 | 9:00 AM
Immunotherapies, including immune checkpoint inhibitors, have emerged as promising treatments for advanced cancers. However, a subset of patients exhibits resistance to such therapies, and t...
MAY 15, 2024 | 6:00 AM
C.E. CREDITS
The Genomes2People Research Program (G2P), led by Robert Green at Brigham and Women’s Hospital, the Broad Institute, Ariadne Labs, and Harvard Medical School, conducts research to acce...
On Demand
C.E. CREDITS
The personalized treatment of each cancer patient with targeted therapies selected based on our understanding of the molecular biology of cancer has been the long-standing goal of precision...